menu
    • menu

    Company profile for Lynk Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lynk Pharmaceuticals: is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. Lynk Pharmaceuticals was founded by veteran drug hunters from Pfizer, Merck and Johnson & Johnson with collectively more than 7 decades of rich experiences in drug discovery. Driven by a higher purpose, Lynk Pharmaceuticals aims at growing into a market leader for ...
    Lynk Pharmaceuticals: is a clinical stage company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. Lynk Pharmaceuticals was founded by veteran drug hunters from Pfizer, Merck and Johnson & Johnson with collectively more than 7 decades of rich experiences in drug discovery. Driven by a higher purpose, Lynk Pharmaceuticals aims at growing into a market leader for developing innovative therapies to address unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lynk PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    291 Fucheng Road, Bldg 5-402, Jianggan, Hangzhou, Zhejiang 310018, China
    Telephone
    Telephone
    +86 0571-87711179
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.lynkpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lynk Pharma Reveals Phase II Results For LNK01004
    Lynk Pharma Reveals Phase II Results For LNK01004

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-key-phase-ii-clinical-results-of-lnk01004-for-the-treatment-of-patients-with-moderate-to-severe-atopic-dermatitis-302618650.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Lynk Pharma Reports Positive Phase 1b Results For LNK01004 In Dermatitis
    Lynk Pharma Reports Positive Phase 1b Results For LNK01004 In Dermatitis

    13 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-positive-results-from-phase-1b-clinical-study-of-lnk01004-for-the-treatment-of-atopic-dermatitis-302219928.html

    PR NEWSWIRE
    13 Aug 2024
    Share Share
    Lynk Announced First Rheumatoid Arthritis Patient Dosed in PIII of LNK01001
    Lynk Announced First Rheumatoid Arthritis Patient Dosed in PIII of LNK01001

    20 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-first-rheumatoid-arthritis-patient-dosed-in-phase--clinical-study-of-lnk01001-302019129.html

    PR NEWSWIRE
    20 Dec 2023
    Share Share
    Lynk Pharmaceuticals Completes Series C2 Financing Round
    Lynk Pharmaceuticals Completes Series C2 Financing Round

    21 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-series-c2-financing-round-with-total-c-round-funding-of-322-million-rmb-301933690.html

    PR NEWSWIRE
    21 Sep 2023
    Share Share
    Lynk hits main goal to wrap up clean sweep of phase 2 JAK trials
    Lynk hits main goal to wrap up clean sweep of phase 2 JAK trials

    23 Aug 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lynk-brushing-eqrx-rejection-hits-main-goal-wrap-clean-sweep-phase-2-jak-trials

    Nick Paul Taylor FIERCE BIOTECH
    23 Aug 2023
    Share Share
    Lynk’s JAK1 inhibitor improves severity, itching in eczema study
    Lynk’s JAK1 inhibitor improves severity, itching in eczema study

    09 Aug 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/after-eqrx-partnership-falls-apart-lynks-mid-stage-eczema-trial-hits-main-goals

    Gabrielle Masson FIERCE BIOTECH
    09 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search